However, we detected alterations in CTCs that were not detected in the matched single-site tumour biopsy, including numerous alterations in MAPK and alternative pathways, with potential relevance for clinical development (e.g., ATM, ATR, etc.). This evidence concerns the gene ATR and neoplasm.